GlassScriptPhysician profile
Xuesong Chen
NPI 1679835284
$1,265.77
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,193 · 2022: $72.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allerderm Laboratories | $989.25 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $116.10 | 2020 | |
| Octapharma USA, INC. | $87.99 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $29.75 | 2022 | |
| Biocryst US Sales Co., LLC | $25.50 | 2022 | |
| Kaleo, INC. | $17.18 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xuesong Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.